These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 7688270)

  • 21. HIV-1-infected children on HAART: immunologic features of three different levels of viral suppression.
    Zaccarelli-Filho CA; Ono E; Machado DM; Brunialti M; Succi RC; Salomão R; Kallás EG; de Moraes-Pinto MI
    Cytometry B Clin Cytom; 2007 Jan; 72(1):14-21. PubMed ID: 17041945
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased proliferation within T lymphocyte subsets of HIV-infected adolescents.
    Starr SE; Sarr M; Campbell DE; Wilson CM; Douglas SD
    AIDS Res Hum Retroviruses; 2002 Nov; 18(17):1301-10. PubMed ID: 12487818
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interleukin-2 induced immune effects in human immunodeficiency virus-infected patients receiving intermittent interleukin-2 immunotherapy.
    Kovacs JA; Vogel S; Metcalf JA; Baseler M; Stevens R; Adelsberger J; Lempicki R; Hengel RL; Sereti I; Lambert L; Dewar RL; Davey RT; Walker RE; Falloon J; Polis MA; Masur H; Lane HC
    Eur J Immunol; 2001 May; 31(5):1351-60. PubMed ID: 11465092
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Studies on the potential use of CD38 expression as a marker for the efficacy of anti-retroviral therapy in HIV-1-infected patients in Thailand.
    Onlamoon N; Tabprasit S; Suwanagool S; Louisirirotchanakul S; Ansari AA; Pattanapanyasat K
    Virology; 2005 Oct; 341(2):238-47. PubMed ID: 16099011
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased activation and expansion of a CD57+ subset within peripheral CD8+ T lymphocytes in Mycobacterium tuberculosis-infected patients.
    Fateminasab FD; Shahgasempour S; Mirsaeidi SM; Tabarsi P; Mansoori SD; Entezami Z
    Arch Iran Med; 2006 Jan; 9(1):53-7. PubMed ID: 16649379
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cell cycling in HIV infection: analysis of in vivo activated lymphocytes.
    Mahalingam M; Pozniak A; McManus TJ; Vergani D; Peakman M
    Clin Exp Immunol; 1995 Dec; 102(3):481-6. PubMed ID: 8536361
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasma levels of viro-immunological markers in HIV-infected and non-infected Ethiopians: correlation with cell surface activation markers.
    Messele T; Brouwer M; Girma M; Fontanet AL; Miedema F; Hamann D; Rinke de Wit TF
    Clin Immunol; 2001 Feb; 98(2):212-9. PubMed ID: 11161977
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased CCR5 and CXCR4 expression in Ethiopians living in Israel: environmental and constitutive factors.
    Kalinkovich A; Borkow G; Weisman Z; Tsimanis A; Stein M; Bentwich Z
    Clin Immunol; 2001 Jul; 100(1):107-17. PubMed ID: 11414751
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Programmed cell death in peripheral lymphocytes from HIV-infected persons: increased susceptibility to apoptosis of CD4 and CD8 T cells correlates with lymphocyte activation and with disease progression.
    Gougeon ML; Lecoeur H; Dulioust A; Enouf MG; Crouvoiser M; Goujard C; Debord T; Montagnier L
    J Immunol; 1996 May; 156(9):3509-20. PubMed ID: 8617980
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Candidate hematopoietic stem cells from fetal tissues, umbilical cord blood vs. adult bone marrow and mobilized peripheral blood.
    Huang S; Law P; Young D; Ho AD
    Exp Hematol; 1998 Nov; 26(12):1162-71. PubMed ID: 9808056
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Relationship between T-subsets and clinical aspects of HIV-associated diseases].
    Fuchs M; Stadler BM; Malinverni R; de Weck AL; Pichler WJ
    Schweiz Med Wochenschr; 1991 Jan; 121(3):57-66. PubMed ID: 1671535
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phenotypic analysis of CD8+ T lymphocytes in a cohort of HIV type 1-infected patients treated with saquinavir, ritonavir, and two nucleoside analogs for 1 year, and association with plasma HIV type 1 RNA.
    Kaufmann GR; Zaunders JJ; Cunningham P; Cooper DA
    AIDS Res Hum Retroviruses; 1999 Jul; 15(11):963-72. PubMed ID: 10445808
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correlation of CD8 lymphocyte activation with cellular viremia and plasma HIV RNA levels in asymptomatic patients infected by human immunodeficiency virus type 1.
    Bouscarat F; Levacher-Clergeot M; Dazza MC; Strauss KW; Girard PM; Ruggeri C; Sinet M
    AIDS Res Hum Retroviruses; 1996 Jan; 12(1):17-24. PubMed ID: 8825614
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CD8+ lymphocyte activation at human immunodeficiency virus type 1 seroconversion: development of HLA-DR+ CD38- CD8+ cells is associated with subsequent stable CD4+ cell levels. The Multicenter AIDS Cohort Study Group.
    Giorgi JV; Ho HN; Hirji K; Chou CC; Hultin LE; O'Rourke S; Park L; Margolick JB; Ferbas J; Phair JP
    J Infect Dis; 1994 Oct; 170(4):775-81. PubMed ID: 7930717
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Production of CD8+ T cell nonlytic suppressive factors by CD28, CD38, and HLA-DR subpopulations.
    Jiang JQ; Balasubramanian S; Hawley-Foss NC; Badley AD; Rosenthal KL; Copeland KF
    AIDS Res Hum Retroviruses; 2003 Jun; 19(6):497-502. PubMed ID: 12882659
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quantitative alterations of the functionally distinct subsets of CD4 and CD8 T lymphocytes in asymptomatic HIV infection: changes in the expression of CD45RO, CD45RA, CD11b, CD38, HLA-DR, and CD25 antigens.
    Benito JM; Zabay JM; Gil J; Bermejo M; Escudero A; Sánchez E; Fernández-Cruz E
    J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Feb; 14(2):128-35. PubMed ID: 9052721
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [T-lymphocyte immune in HIV-infected people and AIDS patients in China].
    Li T; Qiu Z; Wang A; Sheng R
    Zhonghua Yi Xue Za Zhi; 2002 Oct; 82(20):1391-5. PubMed ID: 12509921
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of CD8+ T lymphocyte subsets with the most commonly used markers to monitor HIV type 1 infection in children treated with highly active antiretroviral therapy.
    Navarro J; Resino S; Bellón JM; Abad ML; Gurbindo D; Fernández-Cruz E; Muñóz-Fernández MA
    AIDS Res Hum Retroviruses; 2001 Apr; 17(6):525-32. PubMed ID: 11350666
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activation of CD8 T cells normalizes and correlates with the level of infectious provirus in tonsils during highly active antiretroviral therapy in early HIV-1 infection.
    Dyrhol-Riise AM; Voltersvik P; Olofsson J; Asjö B
    AIDS; 1999 Dec; 13(17):2365-76. PubMed ID: 10597778
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of activation antigens, HLA-DR and CD38, on CD8 lymphocytes during HIV-1 infection.
    Kestens L; Vanham G; Gigase P; Young G; Hannet I; Vanlangendonck F; Hulstaert F; Bach BA
    AIDS; 1992 Aug; 6(8):793-7. PubMed ID: 1418775
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.